Kuwait Recombinant Protein Therapeutics Cdmo Market Size & Outlook
The recombinant protein therapeutics cdmo market in Kuwait is expected to reach a projected revenue of US$ 107.7 million by 2030. A compound annual growth rate of 11.9% is expected of Kuwait recombinant protein therapeutics cdmo market from 2024 to 2030.
Revenue, 2023 (US$M)
$49.0
Forecast, 2030 (US$M)
$107.7
CAGR, 2024 - 2030
11.9%
Report Coverage
Kuwait
Kuwait recombinant protein therapeutics cdmo market, 2018-2030 (US$M)
Related Markets
Kuwait recombinant protein therapeutics cdmo market highlights
- The Kuwait recombinant protein therapeutics cdmo market generated a revenue of USD 49.0 million in 2023 and is expected to reach USD 107.7 million by 2030.
- The Kuwait market is expected to grow at a CAGR of 11.9% from 2024 to 2030.
- In terms of segment, interferons was the largest revenue generating type in 2023.
- Growth Hormones is the most lucrative type segment registering the fastest growth during the forecast period.
Recombinant protein therapeutics cdmo market data book summary
| Market revenue in 2023 | USD 49.0 million |
| Market revenue in 2030 | USD 107.7 million |
| Growth rate | 11.9% (CAGR from 2023 to 2030) |
| Largest segment | Interferons |
| Fastest growing segment | Growth Hormones |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Growth Hormones, Interferons, Vaccines, Immunostimulating Agents |
| Key market players worldwide | Lonza Group Ltd, Catalent Inc, FUJIFILM Holdings Corp, WuXi Biologics (Cayman) Inc, Batavia Biosciences, Richter-Helm, Curia, HALIX, Biovian, Enzene Biosciences |
Other key industry trends
- In terms of revenue, Kuwait accounted for 0.2% of the global recombinant protein therapeutics cdmo market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, Saudi Arabia recombinant protein therapeutics cdmo market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 312.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Recombinant Protein Therapeutics CDMO Market Scope
Recombinant protein therapeutics cdmo market segmentation & scope
Others
Recombinant Protein Therapeutics CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Kuwait recombinant protein therapeutics cdmo market size, by type, 2018-2030 (US$M)
Kuwait Recombinant Protein Therapeutics CDMO Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
